CN111249184B - Transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously - Google Patents
Transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously Download PDFInfo
- Publication number
- CN111249184B CN111249184B CN202010126155.5A CN202010126155A CN111249184B CN 111249184 B CN111249184 B CN 111249184B CN 202010126155 A CN202010126155 A CN 202010126155A CN 111249184 B CN111249184 B CN 111249184B
- Authority
- CN
- China
- Prior art keywords
- wrinkle
- percent
- polypeptide
- water
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 43
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 43
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 43
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 43
- 239000011325 microbead Substances 0.000 title claims abstract description 37
- 239000003921 oil Substances 0.000 claims abstract description 52
- 235000019198 oils Nutrition 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000008367 deionised water Substances 0.000 claims abstract description 12
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 12
- 239000003906 humectant Substances 0.000 claims abstract description 10
- 239000002562 thickening agent Substances 0.000 claims abstract description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 10
- 239000008158 vegetable oil Substances 0.000 claims abstract description 10
- 239000000126 substance Substances 0.000 claims abstract description 7
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical group CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000011324 bead Substances 0.000 claims description 9
- 239000008169 grapeseed oil Substances 0.000 claims description 8
- 229920002148 Gellan gum Polymers 0.000 claims description 7
- 239000000216 gellan gum Substances 0.000 claims description 7
- 235000010492 gellan gum Nutrition 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 229920006037 cross link polymer Polymers 0.000 claims description 6
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 6
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 5
- 240000007817 Olea europaea Species 0.000 claims description 5
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical group OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 4
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 4
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- 241000220225 Malus Species 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 241001252601 Blumea Species 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 abstract description 2
- 229920002545 silicone oil Polymers 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 239000012071 phase Substances 0.000 description 36
- 239000000686 essence Substances 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 23
- 239000002537 cosmetic Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- 239000002245 particle Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000006641 stabilisation Effects 0.000 description 8
- 238000013112 stability test Methods 0.000 description 8
- 238000011105 stabilization Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- RJZNPROJTJSYLC-LLINQDLYSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O RJZNPROJTJSYLC-LLINQDLYSA-N 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 240000001851 Artemisia dracunculus Species 0.000 description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000010773 plant oil Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- PHLASVAENYNAOW-UHFFFAOYSA-N methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C=1C=CC=CC=1)O[Si](C=1C=CC=CC=1)(C)O[Si](C)(C=1C=CC=CC=1)C1=CC=CC=C1 PHLASVAENYNAOW-UHFFFAOYSA-N 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940117985 trimethyl pentaphenyl trisiloxane Drugs 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide at the same time, which comprises the following substances in percentage by mass: 0.5 to 5.0 percent of vegetable fat, 0.0001 to 0.1 percent of fat-soluble anti-wrinkle polypeptide, 0.0001 to 0.9 percent of water-soluble anti-wrinkle polypeptide, 0.15 to 0.3 percent of water-phase thickening agent, 0 to 0.3 percent of pH regulator, 2.0 to 15.0 percent of humectant and the balance of deionized water. The micro-bead essence provided by the invention dissolves fat-soluble anti-wrinkle polypeptide in vegetable oil, is uniformly and stably suspended in the transparent aqueous essence in an oil drop form, does not contain an emulsifier, a solubilizer and a synthetic silicone oil component, and effectively solves the technical problem that the fat-soluble biological polypeptide cannot be directly added into the transparent aqueous essence because of insolubility in water. The microbead essence disclosed by the invention is transparent and attractive in appearance, clear in texture and clear and moist in skin feel, and meanwhile, the fat-soluble anti-wrinkle polypeptide and the water-soluble anti-wrinkle polypeptide are reasonably matched and synergized, so that the microbead essence has a better anti-wrinkle effect.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a micro-bead essence which contains water-soluble anti-wrinkle polypeptide and fat-soluble anti-wrinkle polypeptide, stably suspends plant oil drops, and is transparent and attractive in appearance.
Background
Various physiological processes in the human body are almost all regulated by polypeptides or proteins consisting of specific amino acid sequences, so that biological polypeptides become a brand new direction and thought for cosmetic development and application, and the functions are increasingly subdivided, such as: anti-wrinkle, whitening, repairing, etc. The skin is a natural barrier of the human body against external environmental insults, and has a certain protective effect against external stimuli, which is benefited by the protective effect of the stratum corneum of the skin. But also keeps most of the nutrients of the cosmetics on the surface of the skin, the nutrients need to penetrate through the cell membrane of the stratum corneum to enter the skin, and only a small amount of macromolecules and fat-soluble substances can be absorbed through pores and sweat pores. The bioactive cosmetic polypeptide can easily penetrate through the gaps of the stratum corneum and enter the stratum corneum to play a role.
Palmitoyl pentapeptide-4, which is called micro-collagen, is used as a signal peptide, is used for synthesizing, repairing and reconstructing extracellular matrix by acting on skin fibroblasts, effectively promoting the proliferation of collagen, hyaluronic acid and elastic fibers in the skin, improving the water content of the skin, increasing the thickness of the skin, eliminating static wrinkles, and enhancing the tightness and glossiness of the skin. The combination with fat-soluble palmitic acid enhances skin penetration, but is limited by the fat solubility and cannot be directly added into transparent water aqua cosmetics.
Acetyl hexapeptide-8 is a bioactive polypeptide composed of 6 amino acids through dehydration condensation, and can reduce muscle contraction by inhibiting release of nerve conduction factor acetylcholine, thereby reducing generation of dynamic lines and expression lines. Acetyl hexapeptide-8 is water-soluble anti-wrinkle polypeptide, and the solubility in water is 10mg/mL.
A cosmetic product is a mixture of various components, the properties of which vary more or less from the development stage, the production stage, until the distribution and the actual use by the consumer. Therefore, the stability of cosmetics is an important issue for the quality assurance of cosmetics, which is closely related to the assurance of the function of cosmetics, the degree of acceptance of products by consumers, and the economic benefit of manufacturers. Before the "use date", the cosmetic should ensure no significant change in appearance, odor, etc.
The appearance of cosmetics is closely related to the consumption psychology of cosmetics, and has an important influence on the development and production of cosmetics. Along with the improvement of income level of Chinese consumers, the 'high end' becomes the hottest keyword of the Chinese cosmetic market, the demand of the consumers on high-quality products is continuously improved, not only the product efficacy is emphasized, but also the product appearance with clear texture is more and more favored by more consumers. The transparent appearance brings fresh touch feeling, can enter the skin more quickly, and brings comfortable and pleasant use feeling to consumers.
The particle suspension essence is a cosmetic formulation which is loved and sought by consumers due to the advantages of novel and unique appearance, variable shell shape, high visual perception, active ingredient wrapping and the like. With the continuous optimization of the preparation technology of the particles, the suspended particles are more diversified in form, and the shell of the particles is gradually softened, so that the particles are easily crushed when being smeared and used, and a better use feeling is obtained. But the shell with softer hardness has poor stability and is easy to crush, and the control of the appearance quality of the inner material in the production link and the transportation link of the product is directly influenced; in addition, when the particles are applied, the shell of the particles is poor in compatibility with skin, the absorption time is long, and even the particles are not absorbed by the skin, so that the use feeling of the product is directly influenced.
CN106880581A discloses a stock solution formula with suspended oil bead particles and a process thereof, which comprises 5 to 8 percent of propylene glycol, 2 to 5 percent of glycerol, 2 to 3 percent of glyceryl polyether-26, 0.1 to 0.2 percent of transparent xanthan gum, 0.05 to 0.1 percent of gellan gum, 0.1 to 0.2 percent of sodium hyaluronate, 0.1 to 0.2 percent of hydrolyzed sodium hyaluronate, 1 to 2 percent of amino acid humectant, 0.3 to 0.5 percent of antioxidant, 3 to 5 percent of viscosity regulator, 0.5 to 1 percent of snail secretion filtrate extract, 1 to 2 percent of tremella extract, 0.3 to 0.5 percent of carboxymethyl beta-dextran sodium, 1 to 2 percent of trimethyl pentaphenyl trisiloxane and 70.3 to 83.55 percent of deionized water.
Disclosure of Invention
The invention aims to provide a micro-bead essence which stably suspends plant oil drops, contains water-soluble and fat-soluble anti-wrinkle polypeptides, has a transparent and attractive appearance and has a better anti-wrinkle effect, aiming at the problem that fat-soluble biological polypeptides cannot be directly added in the essence of a transparent water aqua.
Aiming at the purposes, the microbead essence comprises the following substances in percentage by mass:
0.5 to 5.0 percent of vegetable fat, 0.0001 to 0.1 percent of fat-soluble anti-wrinkle polypeptide, 0.0001 to 0.9 percent of water-soluble anti-wrinkle polypeptide, 0.15 to 0.3 percent of water-phase thickening agent, 0 to 0.3 percent of pH regulator, 2.0 to 15.0 percent of humectant and the balance of deionized water.
The transparent microbead essence disclosed by the invention preferably comprises the following substances in percentage by mass:
1.0 to 3.3 percent of vegetable oil, 0.01 to 0.08 percent of fat-soluble anti-wrinkle polypeptide, 0.1 to 0.65 percent of water-soluble anti-wrinkle polypeptide, 0.20 to 0.27 percent of water phase thickening agent, 0.03 to 0.15 percent of pH regulator, 5.0 to 10.0 percent of humectant and the balance of deionized water.
The vegetable oil is one or more of blumea oil, malus agar-agar, grapeseed oil and olive fruit oil, preferably one or more of grapeseed oil and olive fruit oil.
The water phase thickener is a combination of at least two of xanthan gum, gellan gum, carbomer and acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer; preferably a combination of carbomer and xanthan gum, or a combination of gellan gum and an acrylic/C10-30 alkanol acrylate crosspolymer.
The fat-soluble anti-wrinkle polypeptide is palmitoyl pentapeptide-4, and the water-soluble anti-wrinkle polypeptide is acetyl hexapeptide-8.
The pH regulator is at least one of potassium hydroxide, triethanolamine, tris (hydroxymethyl) aminomethane and arginine.
The humectant is more than two of glycerol, propylene glycol, butanediol, pentanediol, hexanediol, and sodium hyaluronate.
The preparation method of the microbead essence comprises the following steps: adding a water phase thickening agent, a pH regulator, a humectant and water-soluble anti-wrinkle polypeptide into deionized water, and fully dissolving to prepare a water phase; fully dissolving fat-soluble anti-wrinkle polypeptide in vegetable oil to prepare an oil phase; and (3) uniformly dispersing the oil phase into the water phase in an oil bead form to prepare the transparent micro-bead essence.
The invention has the following beneficial effects:
1. the invention provides transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide, which is characterized in that the system is a novel water-oil two-phase uniform dispersion system provided after the advantages of refreshing skin feel of a water-based system and good skin compatibility of an oil-based system are combined. The fat-soluble anti-wrinkle polypeptide palmitoyl pentapeptide-4 is dissolved in vegetable oil and is uniformly and stably dispersed and suspended in the water-based transparent anti-wrinkle essence in an oil drop form, so that the technical problem that the fat-soluble biological polypeptide palmitoyl pentapeptide-4 cannot be directly added into the transparent aqueous essence due to the restriction of water insolubility is effectively solved.
2. In the transparent microbead essence, the fat-soluble anti-wrinkle polypeptide palmitoyl pentapeptide-4 and the water-soluble anti-wrinkle polypeptide acetyl hexapeptide-8 are scientifically matched, so that the synergistic effect is achieved, and the transparent microbead essence has a better anti-wrinkle effect.
3. The transparent micro-bead essence disclosed by the invention breaks through the existing emulsification, solubilization and particle wrapping technologies, avoids the adverse stimulation of an emulsifier, a solubilizer and a chemical surfactant to skin, selects natural vegetable oil to replace synthetic silicone oil to prepare a micro-bead matrix, is not wrapped by a shell, is glittering and translucent in appearance, clear and moist in skin feel when in use, is good in stability, and has no unstable phenomena such as layering, turbidity and the like through six-month stability investigation under accelerated conditions such as 4 ℃, 45 ℃, heat freezing circulation, illumination and the like.
Drawings
FIG. 1 is a view showing the appearance of the essence of microbeads according to the present invention.
Detailed Description
The invention will be further described in detail with reference to the following figures and examples, but the scope of the invention is not limited to these examples.
Example 1
Adding 0.09g of gellan gum, 0.06g of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.02g of arginine, 2.0g of glycerol, 2.0g of pentanediol, 0.02g of sodium hyaluronate and 0.1g of acetyl hexapeptide into 94.7g of deionized water for full dissolution to prepare a water phase; adding 0.01g of palmitoyl pentapeptide into 1.0g of malus wallichiana oil for fully dissolving to prepare an oil phase; the oil phase is uniformly dispersed in the water phase in the form of oil beads, and transparent micro-bead essence is prepared (see figure 1).
Example 2
Adding 0.1g of xanthan gum, 0.08g of gellan gum, 3g of butanediol, 2g of hexanediol and 0.2g of acetyl hexapeptide into 93.1g of deionized water for fully dissolving to prepare a water phase; adding 0.02g palmitoyl pentapeptide into 1.5g olive fruit oil, and fully dissolving to prepare an oil phase; and (3) uniformly dispersing the oil phase into the water phase in an oil bead form to prepare the transparent micro-bead essence.
Example 3
Adding 0.12g of xanthan gum, 0.1g of carbomer, 0.1g of triethanolamine, 1.5g of pentanediol, 5g of butanediol, 0.05g of sodium hyaluronate, 1.5g of hexanediol and-8.5 g of acetyl hexapeptide into 88.08g of deionized water for full dissolution to prepare a water phase; adding 0.05g of palmitoyl pentapeptide into 2.5g of olive oil and 0.5g of grape seed oil for sufficient dissolution to prepare an oil phase; and uniformly dispersing the oil phase in the water phase in an oil bead form to prepare the transparent micro-bead essence.
Example 4
Adding 0.12g of carbomer, 0.15g of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.27g of tris (hydroxymethyl) aminomethane, 3g of glycerol, 7g of propylene glycol, 1.8g of hexanediol and 0.7g of acetyl hexapeptide into 81.86g of deionized water for sufficient dissolution to prepare an aqueous phase; adding 0.1g of palmitoyl pentapeptide into 5g of grape seed oil, and fully dissolving to prepare an oil phase; and (3) uniformly dispersing the oil phase into the water phase in an oil bead form to prepare the transparent micro-bead essence.
In order to determine the composition of the raw materials of the present invention, the inventors respectively prepared the raw materials in the mass percentage composition in table 1 into essences, and examined the stability thereof, and the results are shown in table 1.
TABLE 1 stability test results (unit: wt%)
As can be seen from table 1, in sample 1, vegetable fat is not added, and when the addition amount of palmitoyl pentapeptide-4 is only 0.001%, the palmitoyl pentapeptide cannot be directly and stably dissolved in the transparent essence; in sample 2, 0.001% of palmitoyl pentapeptide-4 is dissolved in 0.4% of argy wormwood leaf oil to form an oil phase, and the oil phase is dispersed and suspended in the transparent essence in the form of oil drops, but the oil drops float upwards under the heating conditions of normal temperature and 45 ℃ due to the low content of the oil phase, and do not pass the stability test of 6 months; in sample 3, 0.001% of palmitoyl pentapeptide-4 is dissolved in 0.5% of argy wormwood leaf oil to form an oil phase, the oil phase is dispersed and suspended in transparent essence in the form of oil drops, and the obtained sample passes a 6-month stability test; in sample 4, 0.05% of palmitoyl pentapeptide-4 is dissolved in 3.0% of olive oil to form an oil phase, the oil phase is dispersed and suspended in a transparent essence in the form of oil drops, and the obtained sample passes a 6-month stability test; in the sample 5, 0.5% of palmitoyl pentapeptide-4 is dissolved in 5% of grape seed oil to form an oil phase, the oil phase is dispersed and suspended in transparent essence in the form of oil drops, and the obtained sample passes a stability test for 6 months; in sample 6, 0.5% palmitoyl pentapeptide-4 is dissolved in 5.5% grape seed oil to form an oil phase, and the oil phase is dispersed and suspended in the transparent essence in the form of oil drops, wherein the oil drops aggregate and float to be layered under the heating conditions of normal temperature and 45 ℃ due to the overhigh content of the oil phase, and do not pass the stability test for 6 months.
The inventors further performed stability tests on the transparent microbead essence prepared in examples 1 to 4, and specific test results are shown in table 2.
Table 2 cosmetic stability test results of examples 1 to 4
| Sample(s) | pH value | Whether or not to be transparent | Normal temperature for 6 months | 45 deg.C, 6 months |
| Example 1 | 6.7 | Is that | Stabilization | Stabilization |
| Example 2 | 6.2 | Is that | Stabilization | Stabilization |
| Example 3 | 5.9 | Is that | Stabilization | Stabilization |
| Example 4 | 5.7 | Is that | Stabilization | Stabilization |
As can be seen from Table 2, the cosmetics prepared in examples 1 to 4 of the present invention were all transparent and stable.
The inventor further adds no palmitoyl pentapeptide-4 and olive fruit oil in the formula of the transparent microbead essence in example 3 to obtain a comparative sample, and performs an efficacy comparative test with the transparent microbead essence in example 3, wherein the specific test is as follows:
the test purpose is as follows: the skin of the test subjects were each tested for improvement of the skin of the test subjects using the clear bead serum of example 3 and the comparative sample.
Test object(s): volunteers of 34-60 years old who meet test conditions
The number of test persons: 60 names
And (3) testing period: for 56 days
The test method comprises the following steps: the subjects were randomly divided into two groups of 30 individuals, one group was applied with the clear bead serum of example 3, and the other group was applied with the control sample. The skin of the same part of the volunteer was evaluated before and after application, respectively.
The using method comprises the following steps: after cleaning the face in the morning and evening every day, the product is uniformly smeared on the face and the periphery of eyes by taking a dime size test product, and is gently massaged until the product is absorbed.
The evaluation method comprises the following steps: moisture retention was measured using a skin moisture tester Corneometer CM825 (CK corporation, germany); the wrinkle reduction effect was tested using a human skin rapid optical imaging system (PRIMOS, germany); sa: average depth of wrinkles; the skin elasticity was measured using a skin elasticity tester MPA580 (Courage + Khazaka Co., germany).
The test data are the average values of 30 subjects, and the test data are shown in Table 3.
TABLE 3
The test data in table 3 show that after 56 days of use, the transparent microbead essence in example 3 and the comparative sample can improve the water content of the stratum corneum of the skin, and the improvement rate of the water content of the stratum corneum of the transparent microbead essence in example 3 is 39.76%, which is obviously higher than that of the comparative sample by 6.43%; example 3 the facial wrinkle area of the transparent microbead essence is 19.7%, which is obviously reduced compared with 23.5% of the wrinkle area of the comparative sample; example 3 the skin elasticity value of the clear microbead serum was 0.94, which is significantly higher than the R2 value of the comparative sample, which is 0.79. Therefore, the transparent micro-bead essence in the embodiment 3 has a better trial effect, and the facial skin is firm and has obvious anti-wrinkle effect.
Claims (5)
1. A transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptides is characterized by comprising the following substances in percentage by mass:
0.5 to 5.0 percent of vegetable fat, 0.0001 to 0.1 percent of fat-soluble anti-wrinkle polypeptide, 0.0001 to 0.9 percent of water-soluble anti-wrinkle polypeptide, 0.15 to 0.3 percent of water-phase thickening agent, 0.02 to 0.3 percent of pH regulator, 2.0 to 15.0 percent of humectant and the balance of deionized water;
the vegetable oil is any one or more of blumea oil, malus agar, grape seed oil and olive oil;
the water phase thickener is a combination of at least two of xanthan gum, gellan gum, carbomer and acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer;
the fat-soluble anti-wrinkle polypeptide is palmitoyl pentapeptide-4, and the water-soluble anti-wrinkle polypeptide is acetyl hexapeptide-8;
the humectant is more than two of glycerol, propylene glycol, butanediol, pentanediol, hexanediol and sodium hyaluronate;
the preparation method of the microbead essence comprises the following steps: adding a water phase thickening agent, a pH regulator, a humectant and water-soluble anti-wrinkle polypeptide into deionized water, and fully dissolving to prepare a water phase; fully dissolving fat-soluble anti-wrinkle polypeptide in vegetable oil to prepare an oil phase; and uniformly dispersing the oil phase in the water phase in an oil bead form to prepare the transparent micro-bead essence.
2. The transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously as claimed in claim 1, which is characterized by comprising the following substances in percentage by mass:
1.0 to 3.3 percent of vegetable oil, 0.01 to 0.08 percent of fat-soluble anti-wrinkle polypeptide, 0.1 to 0.65 percent of water-soluble anti-wrinkle polypeptide, 0.20 to 0.27 percent of water phase thickening agent, 0.03 to 0.15 percent of pH regulator, 5.0 to 10.0 percent of humectant and the balance of deionized water.
3. The transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously as claimed in claim 1 or 2, wherein: the vegetable oil is any one or a mixture of grape seed oil and olive fruit oil.
4. The transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously as claimed in claim 1 or 2, which is characterized in that: the water phase thickener is a combination of carbomer and xanthan gum or a combination of gellan gum and acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer.
5. The transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously as claimed in claim 1 or 2, which is characterized in that: the pH regulator is at least one of potassium hydroxide, triethanolamine, tris (hydroxymethyl) aminomethane and arginine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010126155.5A CN111249184B (en) | 2020-02-28 | 2020-02-28 | Transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010126155.5A CN111249184B (en) | 2020-02-28 | 2020-02-28 | Transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111249184A CN111249184A (en) | 2020-06-09 |
| CN111249184B true CN111249184B (en) | 2022-12-02 |
Family
ID=70953050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010126155.5A Active CN111249184B (en) | 2020-02-28 | 2020-02-28 | Transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111249184B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112870092A (en) * | 2021-01-29 | 2021-06-01 | 广州集妍化妆品科技有限公司 | Two-phase essence and preparation method thereof |
| CN114288194B (en) * | 2021-12-30 | 2024-03-22 | 彭氏(惠州)实业发展有限公司 | Double-layer skin care essence without deionized water and preparation method thereof |
| CN115252450B (en) * | 2022-08-30 | 2024-05-17 | 时垠(上海)生物科技有限公司 | Oily composition carrying water-soluble components and application thereof |
| CN115998626B (en) * | 2022-11-15 | 2025-01-28 | 华熙生物科技股份有限公司 | Microbeads for cosmetics and their applications |
| CN115844739B (en) * | 2022-11-15 | 2025-04-04 | 华熙生物科技股份有限公司 | Microbeads for cosmetics and their applications |
| CN116421501A (en) * | 2023-03-23 | 2023-07-14 | 深圳市护家科技有限公司 | Micro-essence composition and preparation method thereof |
| CN116270389A (en) * | 2023-04-10 | 2023-06-23 | 彭氏(惠州)实业发展有限公司 | Essence for tightening and anti-wrinkle and preparation method thereof |
| CN117224420B (en) * | 2023-10-08 | 2024-12-31 | 南京斯拜科生物科技股份有限公司 | Oil-soluble lip-rounding compound peptide and preparation method thereof |
| CN117398322A (en) * | 2023-12-13 | 2024-01-16 | 广州悦瑞化妆品有限公司 | Microbead essence and preparation method thereof |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006273821A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Skin care preparation composed of ultrafine emulsion |
| KR20130119586A (en) * | 2012-04-24 | 2013-11-01 | (주)바이오제닉스 | Immproved feeling and hydrating effect water-in-silicone and silicone-in-water emulsion type using the poly-ionic complex in oil soluble ingredient |
| EP2923693A1 (en) * | 2012-11-26 | 2015-09-30 | Wissen Co., Ltd | Anti-aging cosmetic composition comprising fat-soluble fractions of bee venom, and method for preparing same |
| CN105395423A (en) * | 2015-12-11 | 2016-03-16 | 广东龙湖科技股份有限公司 | Moistening mask liquid without emulsifier and preparation method thereof |
| CN107595732A (en) * | 2017-09-08 | 2018-01-19 | 广州环亚化妆品科技有限公司 | A kind of sensitive skin whitening moisture-retention gel of the oil droplet of essential oil containing suspension and its preparation method and application |
| CN107661230A (en) * | 2017-10-27 | 2018-02-06 | 广州神采化妆品有限公司 | A kind of transparent composition containing oil droplet and its application |
| CN108721132A (en) * | 2018-05-30 | 2018-11-02 | 上海中翊日化有限公司 | A kind of suspension oil droplet toner and preparation method thereof containing Sucrose acetoisobutyrate |
| CN109125208A (en) * | 2018-09-28 | 2019-01-04 | 广东芭薇生物科技股份有限公司 | Micro- solidifying anti-ageing Essence of pearl of one kind and preparation method thereof |
| CN110101627A (en) * | 2019-06-18 | 2019-08-09 | 杭州悦萱堂化妆品有限公司 | A kind of essence dew and preparation method thereof with suspension microballon |
| WO2019177187A1 (en) * | 2018-03-16 | 2019-09-19 | Venn Skincare, Inc. | Method of manufacturing composition material for skin moisturizing containing vehicle having multi-layer globule |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8357360B2 (en) * | 2005-04-23 | 2013-01-22 | E-L Management Corp. | Cosmetic compositions containing an aqueous dispersion of silicone elastomers and methods of use |
| US20140011894A1 (en) * | 2012-05-17 | 2014-01-09 | Kemin Industries, Inc. | Stable Emulsions of Personal Care Products |
| WO2015022641A2 (en) * | 2013-08-12 | 2015-02-19 | Red Gold Agarose Corp. (Panama Incorporated) | A cream-like solid agarose-in-water gel particles suspension as an intermediate cosmetics product |
| KR101661912B1 (en) * | 2016-01-29 | 2016-10-04 | (주)넥스젠바이오텍 | Cosmetic composition for anti-wrinkle and anti-aging comprising green fluorescent protein-human epidermal growth factor fusion protein as effective component |
-
2020
- 2020-02-28 CN CN202010126155.5A patent/CN111249184B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006273821A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Skin care preparation composed of ultrafine emulsion |
| KR20130119586A (en) * | 2012-04-24 | 2013-11-01 | (주)바이오제닉스 | Immproved feeling and hydrating effect water-in-silicone and silicone-in-water emulsion type using the poly-ionic complex in oil soluble ingredient |
| EP2923693A1 (en) * | 2012-11-26 | 2015-09-30 | Wissen Co., Ltd | Anti-aging cosmetic composition comprising fat-soluble fractions of bee venom, and method for preparing same |
| CN105395423A (en) * | 2015-12-11 | 2016-03-16 | 广东龙湖科技股份有限公司 | Moistening mask liquid without emulsifier and preparation method thereof |
| CN107595732A (en) * | 2017-09-08 | 2018-01-19 | 广州环亚化妆品科技有限公司 | A kind of sensitive skin whitening moisture-retention gel of the oil droplet of essential oil containing suspension and its preparation method and application |
| CN107661230A (en) * | 2017-10-27 | 2018-02-06 | 广州神采化妆品有限公司 | A kind of transparent composition containing oil droplet and its application |
| WO2019177187A1 (en) * | 2018-03-16 | 2019-09-19 | Venn Skincare, Inc. | Method of manufacturing composition material for skin moisturizing containing vehicle having multi-layer globule |
| CN108721132A (en) * | 2018-05-30 | 2018-11-02 | 上海中翊日化有限公司 | A kind of suspension oil droplet toner and preparation method thereof containing Sucrose acetoisobutyrate |
| CN109125208A (en) * | 2018-09-28 | 2019-01-04 | 广东芭薇生物科技股份有限公司 | Micro- solidifying anti-ageing Essence of pearl of one kind and preparation method thereof |
| CN110101627A (en) * | 2019-06-18 | 2019-08-09 | 杭州悦萱堂化妆品有限公司 | A kind of essence dew and preparation method thereof with suspension microballon |
Non-Patent Citations (2)
| Title |
|---|
| "In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation";Kraeling, MEK;《CUTANEOUS AND OCULAR TOXICOLOGY》;20140422;第34卷(第1期);第46-52页 * |
| "活性多肽在药妆产品生产中的应用";李谋 等;《化工管理》;20180131(第1期);第78-79页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111249184A (en) | 2020-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111249184B (en) | Transparent microbead essence containing water-soluble and fat-soluble anti-wrinkle polypeptide simultaneously | |
| AU2009213799B2 (en) | Use of natural active substances in cosmetic or therapeutic compositions | |
| EP2827837B1 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails | |
| CN110051587A (en) | A kind of preparation method and application of the anti-apolexis composition containing a variety of sodium hyaluronates | |
| CN107106480A (en) | Cosmetic composition containing Halomonas extractive from fermentative and application thereof | |
| CN110664644B (en) | Skin care composition containing folic acid, essence and preparation method thereof | |
| CN110279638A (en) | A kind of reparation skin skin care compositions and preparation method thereof | |
| FR3077202A1 (en) | USE OF CYCLOPEPTIDES IN COSMETICS | |
| KR101537063B1 (en) | Composition for improving skin condition containing ten vitamins | |
| CN107714559A (en) | One kind is without anti-corrosion deep water supplement skin care item | |
| CN110101627A (en) | A kind of essence dew and preparation method thereof with suspension microballon | |
| CN106389234B (en) | Anti-ageing composition and cosmetics | |
| AU2018204216B2 (en) | Skin mimicking emulsion | |
| CN107854403A (en) | A kind of clean moisture surge treatment formula | |
| CN112675060A (en) | Composition and skin care product for resisting skin aging and preparation method thereof | |
| KR100827244B1 (en) | Skin moisturizing nourishing cream composition with far-infrared radiating effect | |
| CN113730289B (en) | Eye and lip care composition with multiple repairing effects and application thereof | |
| CN115737456A (en) | Skin cleaning scrub cream and preparation method thereof | |
| CA3008110A1 (en) | Skin mimicking emulsion | |
| CH717410A2 (en) | Procedure and personalized dermo-aesthetic system to treat multiple cosmetic skin problems with a single treatment. | |
| CN114250156A (en) | Culture solution of yeast, method for producing same, skin external preparation, and skin cosmetic | |
| CN111728931A (en) | Permeation-promoting composition, anti-aging composition and skin care product | |
| KR100289671B1 (en) | Skin Cosmetic Composition Containing Pine Extract and Saccharide Isomerate | |
| KR20210123011A (en) | Nourishing cream composition for keeping moisture of skin with capability of emitting far infrared ray | |
| JP2006241130A (en) | Function of ameliorating collagen fiber formation and wrinkle and flabbiness of human body skin to enhance lifting effect through using polymer component of water-soluble polysaccharide in bracket fungus of the genus fomes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |